Literature DB >> 34854069

Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.

Z Li1, J Xu1, H Guan1, J Lai1, X Yang1, J Ma2.   

Abstract

BACKGROUND: Circular RNAs (circRNAs) have been identified as vital players in tumors, including papillary thyroid carcinoma (PTC). The purpose of this study is to explore the functions of circ_0059354 on PTC development.
METHODS: Quantitative real-time polymerase chain reaction (qRT-PCR) was conducted to examine the levels of circ_0059354, microRNA-766-3p (miR-766-3p) and ADP ribosylation factor guanine nucleotide exchange factor 1 (ARFGEF1). Cell Counting Kit-8 (CCK-8) assay and colony formation assay were proceeded for cell proliferation ability. Transwell assay was conducted for cell migration and invasion. Tube formation assay was employed to examine the angiogenesis ability. Flow cytometry analysis was adopted for cell apoptosis. Western blot assay was conducted for protein levels. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were utilized to verify the relationships among circ_0059354, miR-766-3p and ARFGEF1. The murine xenograft model was constructed to analyze the function of circ_0059354 in vivo.
RESULTS: Circ_0059354 level was abnormally increased in PTC tissues and cells. Functionally, circ_0059354 silencing suppressed cell proliferation, migration, invasion and angiogenesis and facilitated apoptosis in PTC cells. Circ_0059354 was identified to sponge miR-766-3p, which directly targeted ARFGEF1. Moreover, circ_0059354 directly targeted miR-766-3p to positively regulated ARFGEF1 expression. MiR-766-3p inhibition reversed circ_0059354 knockdown-mediated effect of PTC cell malignant behaviors. Overexpression of miR-766-3p restrained the malignant behaviors of PTC cells, whereas ARFGEF1 elevation reversed the effects. Additionally, circ_0059354 deficiency blocked tumor growth in vivo.
CONCLUSION: Circ_0059354 served as an oncogene in PTC progression through regulating miR-766-3p/ARFGEF1 axis.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  ARFGEF1; PTC; circ_0059354; miR-766-3p

Mesh:

Substances:

Year:  2021        PMID: 34854069     DOI: 10.1007/s40618-021-01713-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  3 in total

1.  Circular RNA circ_0084927 regulates proliferation, apoptosis, and invasion of breast cancer cells via miR-142-3p/ERC1 pathway.

Authors:  Guohua Gong; Jikai She; Danni Fu; Dong Zhen; Bin Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.

Authors:  Jianjie Zhao; Zhirong Li; Yi Chen; Shu Zhang; Lingji Guo; Bo Gao; Yan Jiang; Wuguo Tian; Shuai Hao; Xiaohua Zhang
Journal:  Int J Oncol       Date:  2018-11-01       Impact factor: 5.650

3.  MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.

Authors:  Yu You; Keting Que; Yun Zhou; Zhen Zhang; Xiaoping Zhao; Jianpin Gong; Zuojin Liu
Journal:  Mol Cells       Date:  2018-08-27       Impact factor: 5.034

  3 in total
  2 in total

Review 1.  Function and Clinical Significance of Circular RNAs in Thyroid Cancer.

Authors:  Xuelin Yao; Qiu Zhang
Journal:  Front Mol Biosci       Date:  2022-07-22

Review 2.  A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer.

Authors:  Eman A Toraih; Mohammad H Hussein; Manal S Fawzy; Emad Kandil
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.